Harvard Bioscience (HBIO) Change in Account Payables (2010 - 2020)
Harvard Bioscience (HBIO) posted quarterly Change in Account Payables of -$154000.0 for Q4 2020, down 1500.0% year-over-year from $11000.0 in Q1 2020, and up 73.68% quarter-over-quarter from -$585000.0 in Q3 2020.
Harvard Bioscience (HBIO) Change in Account Payables (2010 - 2020) Analysis & Trends
Harvard Bioscience (HBIO) has reported Change in Account Payables for 11 consecutive years, with -$154000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Change in Account Payables fell 1500.0% year-over-year to -$154000.0; the TTM figure through Dec 2020 stood at $511000.0 (up 124.95% YoY), while the FY2020 annual figure was $511000.0, up 124.95% from the prior year.
- Change in Account Payables improved to -$154000.0 in Q4 2020 per HBIO's latest filing, from -$585000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.0 million in Q4 2018 and bottomed at -$2.7 million in Q1 2016.
- Historically, Change in Account Payables has averaged -$163750.0 across 5 years, with a median of -$125000.0 in 2017.
- On a YoY basis, Change in Account Payables climbed as much as 1641.67% in 2018 and fell as far as 2598.8% in 2018.
- Harvard Bioscience's Change in Account Payables stood at $372000.0 in 2016, then plunged by 135.48% to -$132000.0 in 2017, then jumped by 1641.67% to $2.0 million in 2018, then sank by 99.46% to $11000.0 in 2019, then slumped by 1500.0% to -$154000.0 in 2020.
- Business Quant data shows HBIO's Change in Account Payables at -$154000.0 in Q4 2020, -$585000.0 in Q3 2020, and -$72000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -154,000.00 |
| Dec 31, 2020 | -154,000.00 |
| Sep 30, 2020 | -585,000.00 |
| Sep 30, 2020 | -585,000.00 |
| Jun 30, 2020 | -72,000.00 |
| Jun 30, 2020 | -72,000.00 |
| Mar 31, 2020 | 1.32 Mn |
| Mar 31, 2020 | 1.32 Mn |
| Dec 31, 2019 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Sep 30, 2019 | -677,000.00 |
| Sep 30, 2019 | -677,000.00 |
| Jun 30, 2019 | -1.26 Mn |
| Jun 30, 2019 | -1.26 Mn |
| Mar 31, 2019 | -118,000.00 |
| Mar 31, 2019 | -118,000.00 |
| Dec 31, 2018 | 2.04 Mn |
| Dec 31, 2018 | 2.04 Mn |
| Sep 30, 2018 | -2.24 Mn |
| Sep 30, 2018 | -2.24 Mn |